State Operations Manual (Pub. 100-07), Ch. 3 § 3242
Representative Sample Validation Surveys of Deemed
3242 - Representative Sample Validation Surveys of Deemed
Providers/Suppliers
(Rev. 123, Issued: 10-03-14, Effective: 10-03-14, Implementation: 10-03-14)
The deemed provider/supplier validation survey process is designed to evaluate the
performance of a CMS-approved Medicare accreditation program by determining
whether a provider/supplier that is deemed to be in compliance with the Medicare
conditions on the basis of its accreditation and is, in fact, meeting Medicare health and
safety requirements. Such validation surveys are authorized in accordance with §1864 of
the Act. Moreover, CMS is required under §1875(b) of the Act to provide an annual
report to Congress on the performance of all CMS-approved Medicare accreditation
programs approved under Section 1865 of the Act, including a validation of the
accreditation process.
The SA conducts validation surveys of deemed provider/supplier types in accordance
with established survey protocols for the provider or supplier type.
CO selects a representative sample of deemed providers and suppliers for the SA to
conduct a validation survey and forwards this listing each month to the ROs. Upon
receipt of the monthly list, the RO electronically issues the applicable Form CMS 2802,
depending on the type of provider or supplier, promptly to the SA via the ACO system
deeming tab in the recertification/validation kit. The RO also provides CO via the
designated Sharepoint site a copy of the Form CMS 2802 once it is issued, for tracking
purposes.
The representative sample validation survey is a standard, i.e. full, survey of ALL
conditions applicable to that provider or supplier type. Unless the survey is a mid-cycle
survey (see below), representative sample validation surveys must be conducted within
60 calendar days following the scheduled end date of the accreditation organization
survey. The CO advises the RO of the AO scheduled survey end date, and the RO shares
this information with the SA via the electronic version of the applicable Form CMS 2802.
The SA must not share this information with any outside parties. The SA must also not
request a copy of the AO survey report from the AO, in order to avoid bias in the SA’s
conduct of an independent survey of the provider or supplier.
In addition to the traditional representative sample validation surveys, the CO sample
selection may include deemed facilities at various points in their accreditation cycle (e.g.,
mid-cycle). Generally the assignment of such surveys is not tied to the timing of a
scheduled AO survey, and thus there is no AO survey end date that determines the timing
of the SA’s validation survey. The CO will include any additional instructions (if
applicable) for the conduct of such surveys, including the timeframe for completion of
the survey by the SA.